Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Fatigue 1Cachexia 1

Interventions

Therapeutics 4Exercise 2Early Intervention, Educational 2Acceptance and Commitment Therapy 2clazakizumab 1Yoga 1Vinorelbine 1Uncertainty 1Surveys and Questionnaires 1Sugars 1Sodium Chloride 1Radiotherapy 1Qigong 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Physical Therapy Modalities 1Modafinil 1Minocycline 1Infliximab 1Gemcitabine 1Fluoxetine 1Escitalopram 1Educational Status 1Docetaxel 1Cognitive Behavioral Therapy 1Cisplatin 1Caregivers 1Carboplatin 1Behavior Therapy 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × clazakizumab × Thoracic × Clear all
NCT00866970 2020-07-09

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

CSL Behring

Phase 2 Completed
124 enrolled
Thoracic

Cachexia, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡